Vir Biotechnology is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company passionate about equality, inclusion, and respect. When everyone feels supported and encouraged to give their best, we will collectively deliver outstanding results.
The Vir Biotechnology Structural Biology and Protein Sciences group is seeking an experienced protein scientist to join our dynamic and collaborative team. The successful candidate will be responsible to deliver purified, recombinant protein for structural biology, biochemical, and biophysical studies to support Vir's drug discovery efforts. This individual will also be responsible for the biophysical characterization of proteins and protein complexes, and will be a key member on project teams.
This role is located in our San Francisco headquarters with an expectation of at least 4 days per week in office.
WHAT YOU'LL DO
- Plan the protein production workflow for the generation of antigens, antibodies (various formats), and other proteins in collaboration with project teams.
- Perform all relevant steps of the gene-to-protein process, including construct design, expression, purification, and biochemical/biophysical protein characterization.
- Evaluate target feasibility through research of existing information, such as publications, patents, structures, etc.
- Troubleshoot and optimize expression and purification processes.
- Design and perform biophysical assays to characterize proteins, especially kinetic binding assays (SPR and BLI); and analyze, interpret, and communicate results.
- Perform post-purification modifications such as biotinylation, probe conjugation, etc.
- Manage CROs for gene synthesis, protein production and other tasks as required.
- Represent the Structural Biology and Protein Sciences group and make key contributions in project teams.
- Maintain a current understanding of relevant literature, methodologies and technologies related to protein chemistry as well as to specific drug discovery projects.
- Present results internally and externally.
- Possibility of managing direct reports.
- PhD in biochemistry, biophysics, molecular and cell biology, structural biology or related field and 3+ years of relevant industry experience or MS with 6+ years additional industry experience
- Experience with current protein production methods, techniques, and equipment (e.g., affinity, ion exchange and SEC).
- Demonstrated track record of generating high-quality recombinant protein for structural biology, biophysics or assay development in a timely manner.
- Background in biophysical methods of protein characterization; experience with surface plasmon resonance or bio-layer interferometry is preferred.
- Working knowledge of mammalian expression systems and E. coli.
- Familiarity with antibody engineering and production.
- Prior industry experience required.
#LI-225024411_AA1
#LI-Onsite
The expected salary range for this position is $134,500 to $169,500 Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes: compensation, bonus and equity as well as many other Vir benefits and perks such as: health, dental, vision, life and disability insurance benefits, non-accrual paid time off, company shut down for holidays, commuter benefits, child care reimbursement, education reimbursement, 401K match and lunch each day in the office.
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
Vir Biotechnology is an equal opportunity employer. All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to race, color, religion, sex (including pregnancy), gender, gender identity, gender expression, sexual orientation, age, parental status, marital status, national origin, ancestry, disability, medical condition, genetic information (including family medical history), political affiliation, military service or any other legally protected characteristic.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful discrimination or harassment.
Vir Biotechnology Human Resources leads recruitment and employment for Vir. Unsolicited resumes sent to Vir from recruiters do not constitute any type of relationship between the recruiter and Vir and do not obligate Vir to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, participates in E-Verify.
Candidate Privacy Notice
Top Skills
What We Do
Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden.
Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis B and treatment for chronic hepatitis delta. Our portfolio of broad, potent investigational monoclonal antibodies also targets influenza A and B viruses, COVID-19, respiratory syncytial virus/human metapneumovirus and human papillomavirus, and our investigational T cell vaccine aims to prevent HIV. Explore our full pipeline: https://bit.ly/3tr7FPm
We collaborate with some of the world’s leaders in industry as well as government agencies and non-profit organizations enabling us to rapidly advance cutting-edge scientific discoveries and innovative technologies with the potential to benefit people around the world.
We are proud to have been ranked the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™.
Join us as we pursue our mission to transform lives.
It has come to our attention that there have been various recruitment scams targeting job seekers on LinkedIn. Vir Biotechnology, Inc. is committed to your privacy and will never request sensitive personal information including banking details through email, text message, social media or video software platforms. We also will never request a financial commitment from a candidate as part of the application process. Learn more about Vir’s recruiting process: https://bit.ly/461EgJN
